1170 related articles for article (PubMed ID: 1378095)
21. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
Qi JN; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801
[TBL] [Abstract][Full Text] [Related]
24. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
Porreca F; Burks TF
J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
[TBL] [Abstract][Full Text] [Related]
25. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level.
Hylden JL; Wilcox GL
J Pharmacol Exp Ther; 1983 Aug; 226(2):398-404. PubMed ID: 6192235
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
28. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
Latimer LG; Duffy P; Kalivas PW
J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
[TBL] [Abstract][Full Text] [Related]
29. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
Sbacchi M; La Regina A; Petrillo P; Tavani A
NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
[TBL] [Abstract][Full Text] [Related]
30. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
31. Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat.
Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH; Roques BP
J Pharmacol Exp Ther; 1993 May; 265(2):551-8. PubMed ID: 8098759
[TBL] [Abstract][Full Text] [Related]
32. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
Jiang Q; Sheldon RJ; Porreca F
J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
[TBL] [Abstract][Full Text] [Related]
33. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
34. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
[TBL] [Abstract][Full Text] [Related]
35. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
36. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
Hong EK; Takemori AE
J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928
[TBL] [Abstract][Full Text] [Related]
37. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
38. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
Welch SP; Singha AK; Dewey WL
J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070
[TBL] [Abstract][Full Text] [Related]
39. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
40. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]